Login / Signup

GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation.

François DachySabine FurstBoris CalmelsThomas PagliardiniSamia HarbiBenjamin BouchacourtAnne CallejaClaude LemarieAude CollignonGuillaume MorelFaezeh LegrandElena BekrievaAngela GranataPierre Jean WeillerChristian ChabanonJean Marc Schiano De ColellaNorbert VeyDidier BlaiseRaynier Devillier
Published in: Bone marrow transplantation (2023)
Keyphrases
  • stem cell transplantation
  • allogeneic hematopoietic stem cell transplantation
  • risk factors
  • high dose
  • bone marrow
  • low dose
  • acute myeloid leukemia
  • cord blood